Top Gainers and Losers- Sensex falls 100 points, Nifty closes about 10850, HDFC 2% broken

After opening in the red note of most Asian markets, the Indian market also opens with declines. On Tuesday, the Sensex, which opened below 36200 with a loss of 55 points, but in a short while, the decline has increased. At present, the Sensex is trading around 34130 with a drop of 100 points. On the other hand, the Nifty remains around 10850 with down 30 points.

Top Gainers- ONGC, Sun Pharma, Tata Motors, Dr Reddy's Lab, UltraTech are trading between 1.20% and 2.20% in the Nifty 50.

Top Losers- On top of the top losers, Mahindra & Mahindra got 2.29 percent open with weakness. The same NTPC, Wipro, HDFC, HDFC Bank are also in top losers.

Most Asian market open in negative note

Most Asian markets in red mark open on Tuesdays due to the uncertainty over the trade and relations of China and America. China's Shanghai is open in the red mark, but at the moment it remains flat. Hong Kong's Hongseong index is trading down 0.25 percent.

Free Intraday Trading Tips

What would be result of L&T, NTPC ?

Today would be declared the result of L&T, NTPC, and Arvindo Pharma. and the results of Bank of India and Oil India will also come. Let's know how come the results of veterans?

L&T

According to Experts, In the fourth quarter of the fiscal year 2018, L&T's profits could remain flat with Rs 3,027 crore. In the fiscal year 2017, L&T's profits in the fourth quarter were Rs 3,025 crore. In the fourth quarter of the financial year 2018, L&T's earnings could increase by 12.7 percent to Rs 41,535 crore. In the fourth quarter of the fiscal year 2017, L&T's income was Rs 36,828 crore. 

Arvindo Pharma

According to Experts, In the fourth quarter of the fiscal year 2018, the profit of Arvindo Pharma could increase by 17 percent to Rs 622.65 crore. In the fourth quarter of the fiscal year 2017, the profit of Arvindo Pharma was Rs 532.2 crores. In the fourth quarter of the fiscal year 2018, the earnings of Arvindo Pharma could go increase by 17 percent to Rs 4,260 crore. In the fourth quarter of the fiscal year 2017, the income of Arvindo Pharma was Rs 3,641.6 crores.

NTPC

According to Experts, In the fourth quarter of the fiscal year 2018, NTPC's profits could increase by 28 percent to Rs 2,663 crore. NTPC's profits in the fourth quarter of the fiscal year 2017 were Rs 2,080 crore. In the fourth quarter of the fiscal year 2018, NTPC's earnings could increase by 7.5 percent to Rs 21,950 crore. In the fourth quarter of the fiscal year 2017, NTPC's income was Rs 20,417 crore.

Get 2 Days Free Trial click here